Go through these in order and stop at the first one that applies. If you are reading this for someone else, answer for them.
And for anyone, someone who:
Follow-up should be coordinated with clinicians experienced in the specific amyloid type.
Visits may include a symptom review, physical examination, electrocardiogram, blood tests, and assessment of kidney and liver function.
Heart-related blood markers and repeat imaging may be used to follow the condition, although the schedule depends on the individual situation.
Those taking an ATTR medicine need follow-up for symptoms, heart function, medication tolerance, and progression outside the heart.
Contact the care team if symptoms steadily worsen rather than waiting for the next routine visit.
The article also says
People receiving AL therapy need close monitoring of light-chain levels, blood counts, organ function, infections, and treatment side effects.
At home, it may be useful to track weight, swelling, breathing, blood pressure if advised, and ability to complete usual activities.
Relatives of a person with hereditary ATTR amyloidosis may be offered genetic counseling.
Testing is a personal choice and is best performed with counseling about possible medical and family implications.
Every sign above is quoted from the sofidex article on Cardiac amyloidosis. If you are not sure, err upward — it is always reasonable to be checked.